Literature DB >> 28674974

Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.

Jay S Detsky1,2, Julia Keith3, John Conklin2,4, Sean Symons4, Sten Myrehaug1, Arjun Sahgal1, Chinthaka C Heyn4, Hany Soliman5.   

Abstract

Radiation necrosis is a serious potential adverse event of stereotactic radiosurgery that cannot be reliably differentiated from recurrent tumor using conventional imaging techniques. Intravoxel incoherent motion (IVIM) is a magnetic resonance imaging (MRI) based method that uses a diffusion-weighted sequence to estimate quantitative perfusion and diffusion parameters. This study evaluated the IVIM-derived apparent diffusion coefficient (ADC) and perfusion fraction (f), and compared the results to the gold standard histopathological-defined outcomes of radiation necrosis or recurrent tumor. Nine patients with ten lesions were included in this study; all lesions exhibited radiographic progression after stereotactic radiosurgery for brain metastases that subsequently underwent surgical resection due to uncertainty regarding the presence of radiation necrosis versus recurrent tumor. Pre-surgical IVIM was performed to obtain f and ADC values and the results were compared to histopathology. Five lesions exhibited pathological radiation necrosis and five had predominantly recurrent tumor. The IVIM perfusion fraction reliably differentiated tumor recurrence from radiation necrosis (fmean = 10.1 ± 0.7 vs. 8.3 ± 1.2, p = 0.02; cutoff value of 9.0 yielding a sensitivity/specificity of 100%/80%) while the ADC did not distinguish between the two (ADCmean = 1.1 ± 0.2 vs. 1.2 ± 0.4, p = 0.6). IVIM shows promise in differentiating recurrent tumor from radiation necrosis for brain metastases treated with radiosurgery, but needs to be validated in a larger cohort.

Entities:  

Keywords:  Brain metastases; IVIM; MRI; Radiation necrosis; Stereotactic radiosurgery

Mesh:

Year:  2017        PMID: 28674974     DOI: 10.1007/s11060-017-2545-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  40 in total

1.  Perfusion-related parameters in intravoxel incoherent motion MR imaging compared with CBV and CBF measured by dynamic susceptibility-contrast MR technique.

Authors:  R Wirestam; M Borg; S Brockstedt; A Lindgren; S Holtås; F Ståhlberg
Journal:  Acta Radiol       Date:  2001-03       Impact factor: 1.990

2.  On the precision of diffusion/perfusion imaging by gradient sensitization.

Authors:  J Pekar; C T Moonen; P C van Zijl
Journal:  Magn Reson Med       Date:  1992-01       Impact factor: 4.668

3.  Distinguishing recurrent primary brain tumor from radiation injury: a preliminary study using a susceptibility-weighted MR imaging-guided apparent diffusion coefficient analysis strategy.

Authors:  A Al Sayyari; R Buckley; C McHenery; K Pannek; A Coulthard; S Rose
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-28       Impact factor: 3.825

4.  Clinical and pathological characteristics of brain metastasis resected after failed radiosurgery.

Authors:  Jay Jagannathan; T David Bourne; David Schlesinger; Chun-Po Yen; Mark E Shaffrey; Edward R Laws; Jason P Sheehan
Journal:  Neurosurgery       Date:  2010-01       Impact factor: 4.654

5.  Resection of brain metastases previously treated with stereotactic radiosurgery.

Authors:  Giacomo G Vecil; Dima Suki; Marcos V C Maldaun; Frederick F Lang; Raymond Sawaya
Journal:  J Neurosurg       Date:  2005-02       Impact factor: 5.115

6.  Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease.

Authors:  Stefano Telera; Alessandra Fabi; Andrea Pace; Antonello Vidiri; Vincenzo Anelli; Carmine Maria Carapella; Laura Marucci; Francesco Crispo; Isabella Sperduti; Alfredo Pompili
Journal:  J Neurooncol       Date:  2013-03-25       Impact factor: 4.130

7.  Correlative assessment of tumor microcirculation using contrast-enhanced perfusion MRI and intravoxel incoherent motion diffusion-weighted MRI: is there a link between them?

Authors:  Sotirios Bisdas; Christian Braun; Marco Skardelly; Jens Schittenhelm; Tze Hern Teo; Choon Hua Thng; Uwe Klose; Tong San Koh
Journal:  NMR Biomed       Date:  2014-08-04       Impact factor: 4.044

8.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

Review 9.  The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence.

Authors:  Kashif Parvez; Aatif Parvez; Gelareh Zadeh
Journal:  Int J Mol Sci       Date:  2014-07-03       Impact factor: 5.923

Review 10.  Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases.

Authors:  Hany Soliman; Sunit Das; David A Larson; Arjun Sahgal
Journal:  Oncotarget       Date:  2016-03-15
View more
  17 in total

Review 1.  The Role of Standard and Advanced Imaging for the Management of Brain Malignancies From a Radiation Oncology Standpoint.

Authors:  Robert H Press; Jim Zhong; Saumya S Gurbani; Brent D Weinberg; Bree R Eaton; Hyunsuk Shim; Hui-Kuo G Shu
Journal:  Neurosurgery       Date:  2019-08-01       Impact factor: 4.654

2.  Treatment of Leptomeningeal Carcinomatosis Following Treatment of Cerebellar Metastasis of HER2+ (Human Epidermal Growth Factor Receptor 2 Positive) Breast Cancer: Case Report and Review of Literature.

Authors:  Parker D Smith; Lokeshwar S Bhenderu; Sarayu Kommuri; Erin E Fleener; Jason M Hoover
Journal:  Cureus       Date:  2022-04-10

3.  Trastuzumab emtansine increases the risk of stereotactic radiosurgery-induced radionecrosis in HER2 + breast cancer.

Authors:  Badr Id Said; Hanbo Chen; Katarzyna J Jerzak; Ellen Warner; Sten Myrehaug; Chia-Lin Tseng; Jay Detsky; Zain Husain; Arjun Sahgal; Hany Soliman
Journal:  J Neurooncol       Date:  2022-06-17       Impact factor: 4.506

4.  Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery.

Authors:  Andrei Mouraviev; Jay Detsky; Arjun Sahgal; Mark Ruschin; Young K Lee; Irene Karam; Chris Heyn; Greg J Stanisz; Anne L Martel
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

Review 5.  Current approaches to the management of brain metastases.

Authors:  John H Suh; Rupesh Kotecha; Samuel T Chao; Manmeet S Ahluwalia; Arjun Sahgal; Eric L Chang
Journal:  Nat Rev Clin Oncol       Date:  2020-02-20       Impact factor: 66.675

6.  A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.

Authors:  Susannah Hallal; Ali Azimi; Heng Wei; Nicholas Ho; Maggie Yuk Ting Lee; Hao-Wen Sim; Joanne Sy; Brindha Shivalingam; Michael Edward Buckland; Kimberley Louise Alexander-Kaufman
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

7.  Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab.

Authors:  Stephanie Du Four; Yanina Janssen; Alex Michotte; Anne-Marie Van Binst; Robbe Van den Begin; Johnny Duerinck; Bart Neyns
Journal:  Cancer Med       Date:  2018-08-21       Impact factor: 4.452

Review 8.  Diagnosis and Management of Radiation Necrosis in Patients With Brain Metastases.

Authors:  Balamurugan Vellayappan; Char Loo Tan; Clement Yong; Lih Kin Khor; Wee Yao Koh; Tseng Tsai Yeo; Jay Detsky; Simon Lo; Arjun Sahgal
Journal:  Front Oncol       Date:  2018-09-28       Impact factor: 6.244

9.  Clinical assessment of a biophysical model for distinguishing tumor progression from radiation necrosis.

Authors:  Ammoren E Dohm; Tanner M Nickles; Caroline E Miller; Haley J Bowers; Michael I Miga; Albert Attia; Michael D Chan; Jared A Weis
Journal:  Med Phys       Date:  2021-06-16       Impact factor: 4.506

Review 10.  Intravoxel incoherent motion MRI in neurological and cerebrovascular diseases.

Authors:  André M Paschoal; Renata F Leoni; Antonio C Dos Santos; Fernando F Paiva
Journal:  Neuroimage Clin       Date:  2018-08-31       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.